We assign a fundamental rating of 2 out of 10 to PHIO. PHIO was compared to 525 industry peers in the Biotechnology industry. While PHIO seems to be doing ok healthwise, there are quite some concerns on its profitability. PHIO does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

In the past year PHIO has reported negative net income.
In the past year PHIO has reported a negative cash flow from operations.
In the past 5 years PHIO always reported negative net income.
In the past 5 years PHIO always reported negative operating cash flow.

1.2 Ratios

PHIO has a Return On Assets of -69.13%. This is in the lower half of the industry: PHIO underperforms 62.10% of its industry peers.
The Return On Equity of PHIO (-80.83%) is comparable to the rest of the industry.

		Industry Rank	Sector Rank
ROA	-69.13%
ROE	-80.83%
ROIC	N/A

ROA(3y)-110.57%

ROA(5y)-88.07%

ROE(3y)-133.2%

ROE(5y)-105.54%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

PHIO does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

Compared to 1 year ago, PHIO has more shares outstanding
Compared to 5 years ago, PHIO has more shares outstanding
There is no outstanding debt for PHIO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

PHIO has an Altman-Z score of -15.77. This is a bad value and indicates that PHIO is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of PHIO (-15.77) is worse than 80.00% of its industry peers.
PHIO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	-15.77

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A Current Ratio of 6.90 indicates that PHIO has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 6.90, PHIO is in the better half of the industry, outperforming 69.52% of the companies in the same industry.
A Quick Ratio of 6.90 indicates that PHIO has no problem at all paying its short term obligations.
With a decent Quick ratio value of 6.90, PHIO is doing good in the industry, outperforming 69.71% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	6.9
Quick Ratio	6.9

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 81.87% over the past year.

EPS 1Y (TTM)81.87%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%71.43%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, PHIO will show a very strong growth in Earnings Per Share. The EPS will grow by 23.91% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y75.37%

EPS Next 2Y35.74%

EPS Next 3Y23.91%

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

PHIO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year PHIO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.